Executive Profile

Catherine Angell Sohn PharM.D., CLP Founder and President, Sohn Health Strategies, LLC

Age	Total Calculated Compensation	This person is connected to 3 Board Members in 3 different organizations across 4 different industries. See Board Relationships
59	--

Background

Dr. Catherine Angell Sohn, Cathy, Pharm.D., CLP, is the Founder of Sohn Health Strategies, LLC and serves as its President. Since 2010, Dr. Sohn consults to pharmaceutical, biotechnology, medical device, and consumer healthcare companies in the areas of business strategy, business development and strategic product development. Dr. Sohn has significant industry experience in pharmaceutical and health related sectors based on her leadership and achievements in business ... development and new product development for 28 years at Glaxo Smith Kline. From 1982 to 2010, she was with GlaxoSmithKline plc after holding various pharmaceutical, vaccine and consumer healthcare leadership positions. She served as Senior Vice President of Worldwide Business Development and Strategic Alliances for consumer healthcare division at GlaxoSmithKline plc. Early in her tenure with GSK, Dr. Sohn established the U.S. vaccine business unit for SmithKline Beecham Pharmaceuticals and led the commercialization of Engerix-B Vaccine, which grew to more than $100 million in sales. Subsequently, she led the commercialization of Paxil, which became one of GSK’s top five products in the U.S. Dr. Sohn joined Smith Kline & French (now GSK) in anti-infective medical affairs and later acted as Vice President for worldwide strategic product development for the cardiovascular, pulmonary and metabolic therapeutic areas and was a member of the global executive team for strategic product development. She has been a Director of Jazz Pharmaceuticals plc since July 27, 2012. She serves as an Independent Director of The Dohmen Company. Dr. Sohn has been Director of Landec Corp. since November 14, 2012. She has been a Director of Ariel Pharmaceuticals, Inc. since April 2012. Dr. Sohn is Dean’s Professor and member of the Board of Visitors at the University of Sciences in Philadelphia, PA. Dr. Sohn started her career as Assistant Professor of Clinical Pharmacy at the University of the Sciences in Philadelphia. She serves on the Dean’s Advisory Council for Drexel University School of Public Health, serves on the Ben Franklin Technology Partners Investment Advisory Committee, Ernst & Young’s global Life Science Advisory Board, Springboard Enterprises Life Science Council and the global advisory board of the Healthcare Businesswomen’s Association (HBA). She has also served to the boards of multiple non-profit organizations, including two terms on the Member of Health Advisory Board for the Johns Hopkins University Bloomberg School of Public Health and was vice chair of the Corporate Executive Board of the Philadelphia Museum of Art. She served as Director of Consumer Healthcare Products Association. Dr. Sohn has received numerous awards and honors, including the University of California, San Francisco (USCF), School of Pharmacy, Alumnus of the Year in 2000; the Healthcare Businesswomen’s Association (HBA) Woman of the Year in 2003; and the Licensing Executive Society’s Frank Barnes Mentor Award in 2009. She is a Certified Licensing Professional (C.L.P.). She received Pharmacy Degree from the University of California, San Francisco (UCSF). She also received a Certificate of Professional Development from The Wharton School at the University of Pennsylvania.

Corporate Headquarters -- --, -- -- United States Phone: -- Fax: -- Board Members Memberships Director Consumer Healthcare Products Association 2012-Present Director Landec Corp. 2012-Present Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee Jazz Pharmaceuticals Public Limited Company 2012-Present Independent Director Ariel Pharmaceuticals, Inc. Education Doctorate University of California-San Francisco Other Affiliations Landec Corp. GlaxoSmithKline plc University of California-San Francisco University of Pennsylvania - The Wharton School Jazz Pharmaceuticals Public Limited Company Johns Hopkins Bloomberg School of Public Health Consumer Healthcare Products Association Ariel Pharmaceuticals, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.